"Orphan exclusivity plus patents to 2040". It's in the financial slide.
- Forums
- ASX - By Stock
- Let’s compare valuations based off Acadias price for Daybue
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.49%
!
$14.21

"Orphan exclusivity plus patents to 2040". It's in the financial...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.21 |
Change
-0.070(0.49%) |
Mkt cap ! $1.751B |
Open | High | Low | Value | Volume |
$14.44 | $14.44 | $14.03 | $1.279M | 90.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 322 | $14.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.21 | 106 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 258 | 14.230 |
5 | 569 | 14.220 |
8 | 1494 | 14.210 |
10 | 1672 | 14.200 |
11 | 1838 | 14.190 |
Price($) | Vol. | No. |
---|---|---|
14.250 | 103 | 5 |
14.260 | 678 | 5 |
14.270 | 576 | 4 |
14.280 | 1251 | 5 |
14.290 | 586 | 4 |
Last trade - 12.33pm 07/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online